Search results
Results From The WOW.Com Content Network
Following the news release, shares of the company closed at $43.12, denoting a slight decline in Friday’s trading session. ... NeoGenomics, Inc. (NEO), one of the foremost providers of cancer ...
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH. In 2013, the company launched its sequencing platform [3] and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK ...
AOL latest headlines, entertainment, sports, articles for business, health and world news.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases.
Today's Top U.S. News Story Who are the Mennonites in a Texas community where measles is spreading? The Mennonite population being affected by a measles outbreak in West Texas is part of a larger, loosely affiliated group of churches worldwide with varied beliefs and leadership structures — and with sometimes strained or distant relations ...
In September 2021, Synthetic Genomics Inc. (SGI), a private company located in La Jolla, California, changed its name to Viridos. [1] The company is focused on the field of synthetic biology , especially harnessing photosynthesis with micro algae to create alternatives to fossil fuels. [ 2 ]